elumeo SE
XETRA:ELB
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.86
2.98
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
elumeo SE
Accounts Payable
elumeo SE
Accounts Payable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
elumeo SE
XETRA:ELB
|
Accounts Payable
€10.3m
|
CAGR 3-Years
15%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
||
Adidas AG
XETRA:ADS
|
Accounts Payable
€2.6B
|
CAGR 3-Years
10%
|
CAGR 5-Years
2%
|
CAGR 10-Years
7%
|
||
Hugo Boss AG
XETRA:BOSS
|
Accounts Payable
€562m
|
CAGR 3-Years
19%
|
CAGR 5-Years
18%
|
CAGR 10-Years
11%
|
||
Bijou Brigitte modische Accessoires AG
XETRA:BIJ
|
Accounts Payable
€10.2m
|
CAGR 3-Years
13%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
||
M
|
Ming Le Sports AG
F:ML2
|
Accounts Payable
€80
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-76%
|
CAGR 10-Years
N/A
|
elumeo SE
Glance View
elumeo SE engages in the production and sale of gemstone jewelry. The company is headquartered in Berlin, Berlin and currently employs 242 full-time employees. The company went IPO on 2015-07-03. The firm markets products through its online shop and through live television under the Juwelo, Rocks and Co. and AMAYANI brands. Its core markets are Germany, Italy, France, the Netherlands, Belgium, Spain and the United Kingdom.
See Also
What is elumeo SE's Accounts Payable?
Accounts Payable
10.3m
EUR
Based on the financial report for Jun 30, 2024, elumeo SE's Accounts Payable amounts to 10.3m EUR.
What is elumeo SE's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
11%
Over the last year, the Accounts Payable growth was 39%. The average annual Accounts Payable growth rates for elumeo SE have been 15% over the past three years , 11% over the past five years .